WealthBridge Capital Management LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the third quarter, HoldingsChannel.com reports. The institutional investor purchased 4,791 shares of the conglomerate’s stock, valued at approximately $1,061,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Main Street Group LTD bought a new position in Danaher in the 1st quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher in the second quarter worth $25,000. Marquette Asset Management LLC grew its holdings in shares of Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 73 shares during the last quarter. Evolution Wealth Management Inc. grew its holdings in shares of Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares during the last quarter. Finally, Field & Main Bank bought a new stake in shares of Danaher during the second quarter worth $29,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on DHR. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. The Goldman Sachs Group upped their price target on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Guggenheim increased their price objective on shares of Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Morgan Stanley increased their price objective on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Stifel Nicolaus lowered their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $235.41.
Get Our Latest Stock Report on Danaher
Danaher Trading Down 1.1%
DHR stock traded down $2.63 during trading on Friday, hitting $228.87. The company had a trading volume of 3,516,366 shares, compared to its average volume of 4,667,069. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $214.04 and a 200-day moving average price of $195.97. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a PEG ratio of 2.91 and a beta of 0.76.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.77 EPS. As a group, analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is presently 28.42%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Recommended Stories
- Five stocks we like better than Danaher
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
